89 related articles for article (PubMed ID: 6376022)
1. Symposium of oral hypoglycemic agents on receptor and postreceptor actin of insulin.
Diabetes Care; 1984; 7 Suppl 1():1-129. PubMed ID: 6376022
[No Abstract] [Full Text] [Related]
2. Big deal about a little insulin.
Flier JS
Nat Med; 1999 Jun; 5(6):614-5. PubMed ID: 10371493
[No Abstract] [Full Text] [Related]
3. [Therapy with oral antidiabetics 1983].
Berchtold P; Berger M
Ther Umsch; 1983 Oct; 40(10):883-90. PubMed ID: 6359559
[No Abstract] [Full Text] [Related]
4. Sulfonylureas improve insulin binding and insulin action in non-insulin-dependent diabetes mellitus.
Beck-Nielsen H; Hjøllund E; Pedersen O; Richelsen B; Sørensen NS
Diabetes Care; 1984; 7 Suppl 1():100-5. PubMed ID: 6428842
[TBL] [Abstract][Full Text] [Related]
5. The impact of sulfonylurea treatment upon the mechanisms responsible for the insulin resistance in type II diabetes.
Kolterman OG; Olefsky JM
Diabetes Care; 1984; 7 Suppl 1():81-8. PubMed ID: 6376033
[TBL] [Abstract][Full Text] [Related]
6. [Dihydroxybenzoquinones derivatives: orally-available insulin mimetics].
Tanaka J
Nihon Rinsho; 2002 Sep; 60 Suppl 9():522-7. PubMed ID: 12387045
[No Abstract] [Full Text] [Related]
7. [Analog insulin preparations in patients with type 2 diabetes. Better rapid and brief than sluggish and long].
MMW Fortschr Med; 2005 Nov; 147(46):60. PubMed ID: 16358638
[No Abstract] [Full Text] [Related]
8. Management of type 2 diabetes mellitus with oral antihyperglycaemic therapy.
Desai A; Tandon N
Natl Med J India; 2007; 20(4):192-8. PubMed ID: 18085125
[No Abstract] [Full Text] [Related]
9. [Insulin receptors in type II diabetes treated unsuccessfully with oral hypoglycemic agents. Preliminary results].
Bertoli A; Caputo S; Santini S; Ghirlanda G; Altomonte L; Manna R; Greco AV
Minerva Endocrinol; 1986; 11(2):111-4. PubMed ID: 3785114
[No Abstract] [Full Text] [Related]
10. Sulfonylurea effects on target tissues for insulin.
McCaleb ML; Maloff BL; Nowak SM; Lockwood DH
Diabetes Care; 1984; 7 Suppl 1():42-6. PubMed ID: 6376028
[TBL] [Abstract][Full Text] [Related]
11. Insulin and oral hypoglycemic agents should not be used in combination in the treatment of type 2 diabetes.
Westphal SA; Palumbo PJ
Arch Intern Med; 2003 Aug 11-25; 163(15):1783-5; discussion 1785. PubMed ID: 12912711
[No Abstract] [Full Text] [Related]
12. Platelet dysfunction associated with insulin therapy in patients with type 2 diabetes: please do not throw the baby out with the bathwater!
Scheen AJ; Legrand D
J Am Coll Cardiol; 2007 Feb; 49(5):628; author reply 628-9. PubMed ID: 17276192
[No Abstract] [Full Text] [Related]
13. Oral hypoglycemic agents in type II diabetes mellitus.
Lubbos H; Miller JL; Rose LI
Am Fam Physician; 1995 Nov; 52(7):2075-8. PubMed ID: 7484707
[TBL] [Abstract][Full Text] [Related]
14. Impact of moderate aerobic exercise training on insulin sensitivity in type 2 diabetic men treated with oral hypoglycemic agents: is insulin sensitivity enhanced only in non-obese subjects?
Bense L
Med Sci Monit; 2002 Jun; 8(6):LE23; discussion L24. PubMed ID: 12134782
[No Abstract] [Full Text] [Related]
15. Impact of moderate aerobic exercise training on insulin sensitivity in type 2 diabetic men treated with oral hypoglycemic agents: is insulin sensitivity enhanced only in nonobese subjects?
Poirier P; Tremblay A; Broderick T; Catellier C; Tancrède G; Nadeau A
Med Sci Monit; 2002 Feb; 8(2):CR59-65. PubMed ID: 11859274
[TBL] [Abstract][Full Text] [Related]
16. Non-insulin-dependent diabetes mellitus: a clinical strategy.
Skyler JS
Diabetes Care; 1984; 7 Suppl 1():118-29. PubMed ID: 6376024
[TBL] [Abstract][Full Text] [Related]
17. [Escaping oral hypoglycemic agents in type 2 diabetes: importance and limitations of transitory optimized insulin therapy].
Leutenegger M; Bertin E; Grulet H
Diabetes Metab; 1998 Feb; 24(1):80-4. PubMed ID: 9534015
[No Abstract] [Full Text] [Related]
18. Insulin therapy for type 2 diabetes.
Pergallo-Dittko V
Diabetes Self Manag; 2003; 20(5):17, 21, 23-4. PubMed ID: 14679948
[No Abstract] [Full Text] [Related]
19. [Type 2 diabetes: when and how to start insulin treatment?].
Philippe J
Rev Med Suisse Romande; 2004 Mar; 124(3):129-32. PubMed ID: 15095654
[No Abstract] [Full Text] [Related]
20. Comparison of alterations in insulin signalling pathway in adipocytes from Type II diabetic pregnant women and women with gestational diabetes mellitus.
Tomazic M; Janez A; Sketelj A; Kocijancic A; Eckel J; Sharma PM
Diabetologia; 2002 Apr; 45(4):502-8. PubMed ID: 12032625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
